Dr Reddys Laboratories Stock Total Debt

RDY Stock  USD 73.35  1.04  1.44%   
Dr Reddys Laboratories fundamentals help investors to digest information that contributes to Dr Reddys' financial success or failures. It also enables traders to predict the movement of RDY Stock. The fundamental analysis module provides a way to measure Dr Reddys' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dr Reddys stock.
Total Debt To Capitalization is likely to drop to 0.06 in 2024.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

RDY Total Debt Analysis

Dr Reddys' Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
 2021 2022 2023 2024 (projected)
Other Current Liabilities41.6B48.9B56.2B59.0B
Total Assets296.7B322.9B371.3B206.1B

Total Debt

 = 

Bonds

+

Notes

More About Total Debt | All Equity Analysis

Current Dr Reddys Total Debt

    
  13.47 B  
Most of Dr Reddys' fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Dr Reddys Laboratories is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

RDY Total Debt Driver Correlations

Understanding the fundamental principles of building solid financial models for Dr Reddys is extremely important. It helps to project a fair market value of RDY Stock properly, considering its historical fundamentals such as Total Debt. Since Dr Reddys' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dr Reddys' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dr Reddys' interrelated accounts and indicators.
0.970.96-0.071.0-0.14-0.130.920.990.910.98-0.16-0.2-0.050.961.00.990.990.331.00.040.960.03-0.070.19-0.14-0.180.10.030.020.01
0.971.00.090.97-0.04-0.20.970.960.880.95-0.04-0.160.040.910.970.980.960.320.98-0.090.920.11-0.020.12-0.2-0.140.140.140.120.16
0.961.00.160.96-0.01-0.180.970.930.880.920.02-0.120.10.880.960.970.950.30.96-0.150.90.150.040.07-0.18-0.110.130.20.180.2
-0.070.090.16-0.090.7-0.010.17-0.180.03-0.220.880.540.82-0.28-0.08-0.09-0.1-0.16-0.06-0.85-0.260.690.71-0.550.040.4-0.130.810.820.67
1.00.970.96-0.09-0.16-0.130.910.990.90.98-0.18-0.23-0.060.960.990.990.990.320.990.030.960.03-0.060.24-0.14-0.20.10.030.010.0
-0.14-0.04-0.010.7-0.160.08-0.13-0.230.01-0.270.80.640.86-0.28-0.14-0.19-0.17-0.43-0.15-0.75-0.270.710.73-0.340.120.58-0.620.430.490.22
-0.13-0.2-0.18-0.01-0.130.08-0.28-0.120.19-0.150.310.550.01-0.04-0.17-0.16-0.08-0.27-0.170.19-0.14-0.070.14-0.171.00.42-0.52-0.26-0.23-0.25
0.920.970.970.170.91-0.13-0.280.890.770.89-0.03-0.210.030.810.920.930.90.410.93-0.120.850.11-0.08-0.01-0.27-0.140.310.250.230.3
0.990.960.93-0.180.99-0.23-0.120.890.891.0-0.26-0.26-0.170.980.990.990.980.360.980.160.99-0.1-0.170.27-0.14-0.230.13-0.1-0.12-0.06
0.910.880.880.030.90.010.190.770.890.870.070.140.020.90.890.890.910.130.880.030.870.060.140.170.19-0.02-0.09-0.02-0.01-0.02
0.980.950.92-0.220.98-0.27-0.150.891.00.87-0.31-0.3-0.210.980.980.990.980.380.980.190.99-0.13-0.230.29-0.17-0.250.16-0.13-0.15-0.07
-0.16-0.040.020.88-0.180.80.31-0.03-0.260.07-0.310.850.72-0.32-0.19-0.2-0.18-0.35-0.18-0.7-0.320.70.76-0.490.360.68-0.30.60.640.48
-0.2-0.16-0.120.54-0.230.640.55-0.21-0.260.14-0.30.850.4-0.26-0.23-0.24-0.23-0.34-0.24-0.26-0.270.380.59-0.340.60.75-0.330.180.210.16
-0.050.040.10.82-0.060.860.010.03-0.170.02-0.210.720.4-0.24-0.06-0.11-0.07-0.37-0.04-0.9-0.240.690.76-0.450.040.34-0.530.640.70.3
0.960.910.88-0.280.96-0.28-0.040.810.980.90.98-0.32-0.26-0.240.950.960.970.240.940.240.98-0.16-0.190.38-0.06-0.290.07-0.2-0.22-0.14
1.00.970.96-0.080.99-0.14-0.170.920.990.890.98-0.19-0.23-0.060.950.990.980.351.00.050.960.02-0.10.19-0.18-0.190.120.020.010.0
0.990.980.97-0.090.99-0.19-0.160.930.990.890.99-0.2-0.24-0.110.960.990.990.350.990.080.97-0.03-0.130.22-0.17-0.210.16-0.02-0.040.03
0.990.960.95-0.10.99-0.17-0.080.90.980.910.98-0.18-0.23-0.070.970.980.990.240.980.040.960.02-0.070.24-0.09-0.220.070.01-0.010.0
0.330.320.3-0.160.32-0.43-0.270.410.360.130.38-0.35-0.34-0.370.240.350.350.240.350.30.37-0.34-0.47-0.16-0.29-0.010.51-0.11-0.20.02
1.00.980.96-0.060.99-0.15-0.170.930.980.880.98-0.18-0.24-0.040.941.00.990.980.350.020.950.05-0.080.18-0.18-0.190.130.060.050.03
0.04-0.09-0.15-0.850.03-0.750.19-0.120.160.030.19-0.7-0.26-0.90.240.050.080.040.30.020.24-0.82-0.770.350.15-0.250.3-0.82-0.84-0.47
0.960.920.9-0.260.96-0.27-0.140.850.990.870.99-0.32-0.27-0.240.980.960.970.960.370.950.24-0.19-0.220.33-0.16-0.250.15-0.2-0.23-0.12
0.030.110.150.690.030.71-0.070.11-0.10.06-0.130.70.380.69-0.160.02-0.030.02-0.340.05-0.82-0.190.7-0.17-0.030.42-0.260.780.820.45
-0.07-0.020.040.71-0.060.730.14-0.08-0.170.14-0.230.760.590.76-0.19-0.1-0.13-0.07-0.47-0.08-0.77-0.220.7-0.080.170.26-0.390.640.640.32
0.190.120.07-0.550.24-0.34-0.17-0.010.270.170.29-0.49-0.34-0.450.380.190.220.24-0.160.180.350.33-0.17-0.08-0.21-0.570.08-0.35-0.4-0.29
-0.14-0.2-0.180.04-0.140.121.0-0.27-0.140.19-0.170.360.60.04-0.06-0.18-0.17-0.09-0.29-0.180.15-0.16-0.030.17-0.210.46-0.52-0.22-0.19-0.21
-0.18-0.14-0.110.4-0.20.580.42-0.14-0.23-0.02-0.250.680.750.34-0.29-0.19-0.21-0.22-0.01-0.19-0.25-0.250.420.26-0.570.46-0.270.130.150.04
0.10.140.13-0.130.1-0.62-0.520.310.13-0.090.16-0.3-0.33-0.530.070.120.160.070.510.130.30.15-0.26-0.390.08-0.52-0.270.130.040.28
0.030.140.20.810.030.43-0.260.25-0.1-0.02-0.130.60.180.64-0.20.02-0.020.01-0.110.06-0.82-0.20.780.64-0.35-0.220.130.130.970.76
0.020.120.180.820.010.49-0.230.23-0.12-0.01-0.150.640.210.7-0.220.01-0.04-0.01-0.20.05-0.84-0.230.820.64-0.4-0.190.150.040.970.68
0.010.160.20.670.00.22-0.250.3-0.06-0.02-0.070.480.160.3-0.140.00.030.00.020.03-0.47-0.120.450.32-0.29-0.210.040.280.760.68
Click cells to compare fundamentals
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Competition

RDY Long Term Debt

Long Term Debt

5.75 Billion

At this time, Dr Reddys' Long Term Debt is fairly stable compared to the past year.
Based on the latest financial disclosure, Dr Reddys Laboratories has a Total Debt of 13.47 B. This is 389.69% higher than that of the Pharmaceuticals sector and significantly higher than that of the Health Care industry. The total debt for all United States stocks is 153.36% lower than that of the firm.

RDY Total Debt Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dr Reddys' direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dr Reddys could also be used in its relative valuation, which is a method of valuing Dr Reddys by comparing valuation metrics of similar companies.
Dr Reddys is currently under evaluation in total debt category among related companies.

Dr Reddys Institutional Holders

Institutional Holdings refers to the ownership stake in Dr Reddys that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Dr Reddys' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Dr Reddys' value.
Shares
Gqg Partners Llc2023-12-31
437 K
Ameriprise Financial Inc2023-09-30
434.5 K
Millennium Management Llc2023-09-30
361.6 K
Grantham, Mayo, Van Otterloo & Co., Llc2023-12-31
329.1 K
Lazard Asset Management Llc2023-09-30
306.1 K
Acadian Asset Management Llc2023-09-30
270.3 K
Schroder Investment Management Group2023-12-31
266.7 K
Mondrian Investment Partners Ltd2023-09-30
216.1 K
Assenagon Asset Management Sa2023-12-31
196.1 K
Blackrock Inc2023-12-31
M
Royal Bank Of Canada2023-09-30
2.1 M

RDY Fundamentals

About Dr Reddys Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Dr Reddys Laboratories's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dr Reddys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dr Reddys Laboratories based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Last ReportedProjected for 2024
Total Debt To Capitalization 0.06  0.06 

Currently Active Assets on Macroaxis

When determining whether Dr Reddys Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Dr Reddys' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Dr Reddys Laboratories Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Dr Reddys Laboratories Stock:
Check out Dr Reddys Piotroski F Score and Dr Reddys Altman Z Score analysis.
Note that the Dr Reddys Laboratories information on this page should be used as a complementary analysis to other Dr Reddys' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Complementary Tools for RDY Stock analysis

When running Dr Reddys' price analysis, check to measure Dr Reddys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dr Reddys is operating at the current time. Most of Dr Reddys' value examination focuses on studying past and present price action to predict the probability of Dr Reddys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dr Reddys' price. Additionally, you may evaluate how the addition of Dr Reddys to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Is Dr Reddys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dr Reddys. If investors know RDY will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dr Reddys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.103
Dividend Share
40
Earnings Share
3.75
Revenue Per Share
272.4618
Quarterly Revenue Growth
0.066
The market value of Dr Reddys Laboratories is measured differently than its book value, which is the value of RDY that is recorded on the company's balance sheet. Investors also form their own opinion of Dr Reddys' value that differs from its market value or its book value, called intrinsic value, which is Dr Reddys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dr Reddys' market value can be influenced by many factors that don't directly affect Dr Reddys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dr Reddys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Dr Reddys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dr Reddys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.